Arbutus Biopharma Inc.
The UBC Department of Pathology and Laboratory Medicine offers a remarkable opportunity to study with numerous world renowned faculty and research programs. We are recognized as national and international leaders in both basic and clinical research. Experimental Pathology refers to research in any area of biomedical investigation that is relevant to human disease. Since it is necessary to understand the normal working of the system to fully define the changes associated with disease, the areas represented at UBC cover a wide range of fields and approaches. Work at all levels of biological organization is involved, from protein to lipoprotein biochemistry and molecular biology through cell and tumour biology, animal models for studies on pulmonary and cardiovascular pathophysiology and viral and bacterial infection processes, to clinical studies on human population and the AIDS epidemic.
We train students with varied backgrounds in science and medicine including: biochemistry, physiology, cell biology and microbiology/immunology.
We are committed to effective, cutting-edge, ethical research. The results of which will reach beyond the academic realm to effect positive change in the lives of our families, communities and, ultimately, our world.
The Faculty of Graduate and Postdoctoral Studies establishes the minimum admission requirements common to all applicants, usually a minimum overall average in the B+ range (76% at UBC). The graduate program that you are applying to may have additional requirements. Please review the specific requirements for applicants with credentials from institutions in:
Each program may set higher academic minimum requirements. Please review the program website carefully to understand the program requirements. Meeting the minimum requirements does not guarantee admission as it is a competitive process.
Applicants from a university outside Canada in which English is not the primary language of instruction must provide results of an English language proficiency examination as part of their application. Tests must have been taken within the last 24 months at the time of submission of your application.
Minimum requirements for the two most common English language proficiency tests to apply to this program are listed below:
Overall score requirement: 100
Overall score requirement: 7.0
Some programs require additional test scores such as the Graduate Record Examination (GRE) or the Graduate Management Test (GMAT). The requirements for this program are:
The GRE is required by some applicants. Please check the program website.
All applicants have to submit transcripts from all past post-secondary study. Document submission requirements depend on whether your institution of study is within Canada or outside of Canada.
A minimum of three references are required for application to graduate programs at UBC. References should be requested from individuals who are prepared to provide a report on your academic ability and qualifications.
Many programs require a statement of interest, sometimes called a "statement of intent", "description of research interests" or something similar.
Students in research-based programs usually require a faculty member to function as their supervisor. Please follow the instructions provided by each program whether applicants should contact faculty members.
Permanent Residents of Canada must provide a clear photocopy of both sides of the Permanent Resident card.
All applicants must complete an online application form and pay the application fee to be considered for admission to UBC.
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,767.18||$3,104.64|
|Tuition per year|
(plus annual increase, usually 2%-5%)
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$1,057.05 (approx.)|
|Costs of living (yearly)||starting at $17,366.20 (check cost calculator)|
Applicants to UBC have access to a variety of funding options, including merit-based (i.e. based on your academic performance) and need-based (i.e. based on your financial situation) opportunities.
All full-time students who begin a UBC-Vancouver PhD program in September 2018 or later will be provided with a funding package of at least $24,000 for each of the first four years of their PhD. The funding package may consist of any combination of internal or external awards, teaching-related work, research assistantships, and graduate academic assistantships. Please note that many graduate programs provide funding packages that are substantially greater than $24,000 per year. Please check with your prospective graduate program for specific details of the funding provided to its PhD students.
All applicants are encouraged to review the awards listing to identify potential opportunities to fund their graduate education. The database lists merit-based scholarships and awards and allows for filtering by various criteria, such as domestic vs. international or degree level.
Graduate programs may have Teaching Assistantships available for registered full-time graduate students. Full teaching assistantships involve 12 hours work per week in preparation, lecturing, or laboratory instruction although many graduate programs offer partial TA appointments at less than 12 hours per week. Teaching assistantship rates are set by collective bargaining between the University and the Teaching Assistants' Union.
Many professors are able to provide Research Assistantships (GRA) from their research grants to support full-time graduate students studying under their direction. The duties usually constitute part of the student's graduate degree requirements. A Graduate Research Assistantship is a form of financial support for a period of graduate study and is, therefore, not covered by a collective agreement. Unlike other forms of fellowship support for graduate students, the amount of a GRA is neither fixed nor subject to a university-wide formula. The stipend amounts vary widely, and are dependent on the field of study and the type of research grant from which the assistantship is being funded. Some research projects also require targeted research assistance and thus hire graduate students on an hourly basis.
Canadian and US applicants may qualify for governmental loans to finance their studies. Please review eligibility and types of loans.
All students may be able to access private sector or bank loans.
Many foreign governments provide support to their citizens in pursuing education abroad. International applicants should check the various governmental resources in their home country, such as the Department of Education, for available scholarships.
The possibility to pursue work to supplement income may depend on the demands the program has on students. It should be carefully weighed if work leads to prolonged program durations or whether work placements can be meaningfully embedded into a program.
Canadian residents with RRSP accounts may be able to use the Lifelong Learning Plan (LLP) which allows students to withdraw amounts from their registered retirement savings plan (RRSPs) to finance full-time training or education for themselves or their partner.
Please review Filing taxes in Canada on the student services website for more information.
Applicants have access to the cost calculator to develop a financial plan that takes into account various income sources and expenses.
85 students graduated between 2005 and 2013: 1 graduate is seeking employment; for 8 we have no data (based on research conducted between Feb-May 2016). For the remaining 76 graduates:
These statistics show data for the Doctor of Philosophy in Pathology and Laboratory Medicine (PhD). Data are separated for each degree program combination. You may view data for other degree options in the respective program profile.
|2018||Dr. Cheng developed a new clinically relevant experimental model of traumatic brain injury, which is now being used in different research laboratories. This new model has facilitated the study of the pathological development after concussions. This research illuminates the relationship between traumatic brain injuries and subsequent brain diseases.|
|2018||Dr. Chen identified three membrane-associated proteins involved in antioxidant pathways as potential storage quality markers for red cell concentrates. These protein biomarkers hint at the role of oxidative damage in transfusion product quality deterioration. Her research also provided insight into the management and delivery of blood products.|
|2018||Dr. Deng developed a novel strategy to treat non-small-cell lung cancer (or NSCLC) using coxsackievirus type B3 (or CVB3). His studies demonstrated that CVB3 could specifically target and kill KRAS-mutant NSCLC, a non-curable subtype, with minimal damage to normal organs. This finding will aid in the development of oncolytic virotherapy for patients unable to have surgery.|
|2018||Dr. Lim uncovered a novel mechanism for how the cancer-causing gene K-RAS modulates antioxidant levels within cancer cells to protect them from damaging free radicals and in order to support cancer initiation and growth. This research presents a new therapeutic strategy for the treatment of difficult-to-treat cancers driven by K-RAS.|
|2017||Dr. Fernando investigated the role of extracellular vesicles in Amyotrophic Lateral Sclerosis or ALS. Her findings revealed that specific vesicle populations are capable of transmitting protein misfolding to recipient cells. This research provides novel evidence for the role of extracellular vesicles in human ALS disease.|
|2017||Blood clots affect millions of people every day. Through her research, Dr. Carter identified a novel mechanism by which new generation anticoagulants enhance the breakdown of clots. Her findings are of particular interest in the treatment of thrombosis.|
|2017||Dr. Qiu studied the interplay of heart cells and coxsackievirus B3, a virus causing lethal heart diseases. He clarified the modulation and role of two cardiac proteins in supporting viral survival. His research advances our understanding of viral infection in the heart and provides potential drug targets for the treatment of infectious heart diseases.|
|2017||Dr. Burrows identified and characterized a vitamin A responsive transcription factor expressed in immune cells of the intestine and uncovered its role in the development of inflammatory bowel disease.|
|2017||Dr. Arbaeen studied the effectiveness of platelet concentrates in blood transfusions. He investigated the ability of platelet activation and clot formation in a manner that more closely models these same processes in the bloodstream. This work furthers our understanding of blood product functionality and will improve the quality of blood transfusions.|
|2017||Dr. Bagheri studied genetic causes of human prenatal and postnatal developmental abnormalities. Using multiple approaches including bioinformatics, patient cell and transgenic zebrafish analysis, he identified three new genes for developmental disorders. His study represents a blueprint for future genetic studies of abnormal human development.|
Experimental Pathology refers to research in any area of biomedical investigation that is relevant to human disease. Since it is necessary to understand the normal working of the system to fully define the changes associated with disease, the areas represented at UBC cover a wide range of fields and approaches. Work at all levels of biological organization is involved, from protein to lipoprotein biochemistry and molecular biology through cell and tumour biology, animal models for studies on pulmonary and cardiovascular pathophysiology and viral and bacterial infection processes, to clinical studies on human population and the AIDS epidemic.